方法：对65例98眼糖尿病合并白内障的患者行超声乳化白内障摘除及人工晶状体植入术的临床资料进行回顾性分析。统计术后1，30d的视力，术后视力与糖尿病病程的关系以及观察术后并发症。

结果：术后1d，裸眼视力>0.5者69眼(70.4%)，0.3～0.5者18眼(18.4%)，0.1～0.25者8眼(8.2%)，<0.1者3眼(3.1%)。术后30d，裸眼视力>0.5者80眼(81.6%)，0.3～0.5者12眼(12.2%)，0.1～0.25者4眼(4.1%)，<0.1者2眼(2.0%)。糖尿病病程越长，术后视力提高越不理想。术后并发症主要有角膜水肿，前房纤维素性渗出，虹膜粘连，继发青光眼。

结论：超声乳化白内障摘除联合人工晶状体植入术治疗糖尿病性白内障是安全有效的，术后视力的恢复与糖尿病病程及糖尿病视网膜病变有关。

METHODS:Totally 65 cases 98 eyes of diabetic patients with phacoemulsification and intraocular lens implantation were retrospectively observed. Statistics analysis including visual acuity of 1 day, 30 days after surgery, complications, and the correlation between visual acuity and the duration of diabetes.

RESULTS: On the 1^st day after surgery, uncorrected visual acuity> 0.5 in 69 eyes(70.4%), 0.3 to 0.5 in 18 eyes(18.4%), 0.1 to 0.25 in 8 eyes(8.2%), and <0.1 in 3 eyes(3.1%). While on the 30^th day after surgery, visual acuity> 0.5 in 80 eyes(81.6%), 0.3 to 0.5 in 12 eyes(12.2%), 0.1 to 0.25 in 4 eyes(4.1%), <0.1 in 2 eyes(2.0%). Complications included corneal edema, anterior chamber fibrin exudation, synechia and secondary glaucoma.

CONCLUSION: Phacoemulsification and intraocular lens implantation for the treatment of diabetic cataract is safe and effective. The recovery of visual acuity is relative to the duration of diabetes and diabetic retinopathy.